Friday, December 27, 2019 3:51:12 PM
In other companies they've given much the same sort of guidance that NWBO has in essentially giving the status of the trial as being near the point of unblinding. In some cases the trial results were positive, in others negative, but it really didn't matter, the company did it essentially the same way. Once the top line data was revealed, the company generally announced a conference call and webcast to discuss the data and the direction being taken from there.
I would hope that if such a conference call is announced it happens after at least a few hours after the TLD announcement. I say this because on more than one occasion that wasn't the case. A release was put out at 8 a.m. EST, and a webcast was conducted at 9 a.m., as a West Coast investor all was over before I ever got out of bed. As soon as I looked at the quote price I knew something was up, but I was hours behind before I knew what. Companies used to do such things after the market close, but Analysts are largely on East Coast time, and they prefer not staying after the market close, so most such presentations have been scheduled before the open. Admittedly, even when I know a call is coming at 6 a.m. or earlier I'll usually choose not to get up for it, but it's nice to at least have the choice, and on occasion I do set an alarm and listen in live. Hearing the webcast after the fact isn't nearly the same, as by the time I've heard it I've already read the impression of others at cites like this one.
Gary
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM